Skip to content
Review Open access

Assessment of a comprehensive hereditary cancer education program for advanced practice providers in the community oncology setting.

Oct 2026 · JCO Oncology Practice · 0 citations

Abstract

706 Background: Germline genetic testing for hereditary cancer syndromes is becoming mainstream in oncology care. Despite this, genetics education remains lacking for oncology providers, including medical oncologists and advanced practice providers. Additionally, access to a genetic counselor may be challenging, especially in the community oncology setting. Methods: The team of genetic counselors at Texas Oncology created a CME-accredited standardized training program using core competencies from multiple professional organizations including NCCN, ASCO, and NSGC in fall 2024. This training consists of didactic pre-recorded content, interactive live sessions, homework, and one-on-one clinical training. Participants complete a multiple-choice assessment before and after training to evaluate baseline knowledge and quantify learning achieved through didactic instruction. Test results inform revisions of training materials for future participants. Results: 54 APPs have completed the hereditary cancer education course (18 fall 2024, 8 spring 2025, 12 fall 2025, 16 spring 2026). The post-training test average scores across the 4 groups improved from the pre-training test (Table). As expected, individuals with high pre-training scores showed less improvement post-training, while those with lower pre-training scores improved significantly. Conclusions: The overall improvement in post-training test scores indicates that the didactic training provided increases genetics knowledge in 52/53 (98.1%) of providers that completed training. The only exception had high baseline performance (95.7% pre vs. 91.3% post). After reviewing the first three cohorts, training was revised to address knowledge gaps, adding interactive sessions and homework on breast cancer risk models. This improved knowledge and understanding of breast chemoprevention, with 80% of spring 2026 trainees answering correctly. Pancreatic screening remained challenging, likely due to updated NCCN guidelines. Complex topics, such as mosaicism, continue to be a challenge for oncology care providers, indicating the continued importance of access to genetics experts such as certified genetic counselors. Training Group Pre-Training Test (% correct) Post-Training Test (% correct) % Change Fall 2024 (n=18) 57.6 (43.3 - 74.6) 79.3 (56.7 - 95.5) 37.7 (11.8 – 73.6) Spring 2025 (n=8) 56.3 (42.0 - 68.1) 80.1 (75.3 - 89.8) 43.3 (24.5 - 88.1 Fall 2025 (n=12) 58.8 (42.0 - 95.7) 83.8 (68.1 - 92.8) 42.3 (-4.6 - 93.9) Spring 2026 (n=16) 55.8 (32.3 - 93.8) 85.3 (73.8 - 96.9) 52.9 (2.6 – 143.0)

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.